Share this page K
Description: Spanish fund specialized in biomedicine and life sciences projects in early stages.
Vintage year: 2012 (The fund expects to invest in 10 or 12 innovative initiatives that contribute to the development of the Sciences of life and the biomedical technology in 4 year).
Financing stages: development capital.
Geographic preferences: Spain.
Sector preferences: biomedicine and health sciences.
Typical investment: up to 15% of the fund.
Typical investee: innovative companies.
Portfolio: Oncovision (GEM Imaging SA), Amadix, Raman Health, Iden Biotechnology, Health in code, Nuubo, Mecwins.
Participants: Neotec Venture capital initiative promoted by the Center for Industrial technological development (CDTI) and the European Investment Fund (EIF) as well as with other public funds, managed by Axis holdings business and Enisa. The Fund has other private investors among which there is the own management team, several “Family Office” as well as some original investors of CRB.
Other investment criteria: priority will be given to innovative projects that contribute to medicine and to generate employment.